Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

20.34
Delayed Data
As of May 27
 +0.33 / +1.65%
Today’s Change
12.25
Today|||52-Week Range
33.74
+12.19%
Year-to-Date

Today’s Trading

Previous close20.01
Today’s open20.20
Day’s range20.13 - 20.73
Volume864,020
Average volume (3 months)2,027,784
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+73.07%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.92

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-0.32-1.16%
DNAIProNAi Therapeutics ...-0.58-9.06%
OASMOasmia Pharmaceutica...-0.03-0.64%
NEPTNeptune Technologies...+0.07+5.94%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts

Partner Offers

Search for Jobs